Statin use vs. average non-HDL cholesterol levels in Palau

Palau: Statin use vs. average non-HDL cholesterol levels was 3.2 in 2018. ▼ Falling

Latest (2018)
3.2
Change on year
unchanged
World rank
118th
of 191 countries
All-time high
3.8
in 1983
All-time low
3.2
in 2017
Years of data
39
1980–2018

Statin use vs. average non-HDL cholesterol levels in Palau, 1980–2018

012341980199920181980: 3.71981: 3.71982: 3.71983: 3.81984: 3.81985: 3.81986: 3.81987: 3.81988: 3.81989: 3.81990: 3.81991: 3.81992: 3.81993: 3.81994: 3.81995: 3.81996: 3.81997: 3.81998: 3.71999: 3.72000: 3.72001: 3.72002: 3.62003: 3.62004: 3.62005: 3.52006: 3.52007: 3.52008: 3.52009: 3.42010: 3.42011: 3.42012: 3.42013: 3.32014: 3.32015: 3.32016: 3.32017: 3.22018: 3.2

Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.

Analysis

The most recent figure for statin use vs. average non-hdl cholesterol levels in Palau is 3.2, measured in 2018. That is the lowest value across all 39 years on record.

The figure is down 8.6% over ten years.

Over the whole period, statin use vs. average non-hdl cholesterol levels in Palau peaked at 3.8 in 1983 and was at its lowest, 3.2, in 2017.

That places Palau 118th out of 191 countries with data for 2018, putting it in the middle of the range.

The long-run direction has been consistently falling across the 39 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
1980s 3.77 3.7 3.8 10
1990s 3.78 3.7 3.8 10
2000s 3.56 3.4 3.7 10
2010s 3.31 3.2 3.4 9

Countries ranked near Palau

  1. 118 Armenia 3.2 compare
  2. 118 Australia 3.2 compare
  3. 118 Belarus 3.2 compare
  4. 118 Canada 3.2 compare
  5. 118 Denmark 3.2 compare
  6. 118 East Timor 3.2 compare
  7. 118 India 3.2 compare
  8. 118 Iran 3.2 compare
  9. 118 Kyrgyzstan 3.2 compare
  10. 118 Moldova 3.2 compare
  11. 118 Nepal 3.2 compare
  12. 118 Saint Vincent and the Grenadines 3.2 compare
  13. 118 Tanzania 3.2 compare
  14. 118 Venezuela 3.2 compare

See the full ranking of 191 places →

More reference data data for Palau

All data for Palau →

Frequently asked questions

What is statin use vs. average non-hdl cholesterol levels in Palau?
Statin use vs. average non-hdl cholesterol levels in Palau was 3.2 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
What is the highest statin use vs. average non-hdl cholesterol levels recorded in Palau?
The highest recorded value was 3.8 in 1983.
What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Palau?
The lowest recorded value was 3.2 in 2017.
How does Palau rank for statin use vs. average non-hdl cholesterol levels?
Palau ranks 118th out of 191 countries with data for 2018.
Is statin use vs. average non-hdl cholesterol levels rising or falling in Palau?
Over the last ten years it is down 8.6%. The long-run trend across the full record is falling.
Where does this Palau data come from?
The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.